Extended antenatal antiretroviral use correlates with improved infant outcomes throughout the first year of life

AIDS

Volumn 24, Issue 18, 2010, Pages 2819-2826

  Marazzi, Maria C ^a   Liotta, Giuseppe ^a   Nielsen Saines, Karin ^a   Haswell, Jere ^a   Magid, Nurja A ^a   Buonomo, Ersilia ^a   Scarcella, Paola ^a   Altan, Anna M Doro ^a   Mancinelli, Sandro ^a   Palombi, Leonardo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antenatal triple antiretroviral therapy; HIV; Infant outcomes; Maternal HAART; Prevention of mother to child transmission

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; ARTICLE; BODY WEIGHT; CHILD DEATH; COHORT ANALYSIS; DISEASE FREE SURVIVAL; DRUG EFFECT; DRUG USE; FEMALE; FOLLOW UP; GROWTH DISORDER; HEALTH CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LIVE BIRTH; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALAWI; MALNUTRITION; MOZAMBIQUE; NEWBORN INFECTION; PRACTICE GUIDELINE; PREGNANT WOMAN; PRENATAL PERIOD; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; STEVENS JOHNSON SYNDROME; TREATMENT OUTCOME; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ADULT; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; KAPLAN-MEIER ESTIMATE; MALAWI; MALE; MOZAMBIQUE; NEVIRAPINE; PREGNANCY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78549277501     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833ff58c     Document Type: Article

References (17)

1. Dorenbaum A, Cunningham CK, Gelber RD, Culnane M, Mofenson L, Britto P, et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA 2002; 288:189-198.
2. Cooper ER, Charurat M, Burns DN, Blattner W, Hoff R. Trends in antiretroviral therapy and mother-infant transmission of HIV. The Women and Infants Transmission Study Group. J Acquir Immune Defic Syndr 2000; 24:45-47.
3. Nielsen-Saines K, Melo M, Varella I, Fonseca R, Lira R, Turella ML, et al. Primary HIV-1 infection during pregnancy: high rate of HIV-1 MTCT in a cohort of patients in southern Brazil.4th Dominique Dormont International Conference. Maternal chronic viral infections transmitted to infants: from mechanisms to prevention and care. Retrovirology 2008; 5:O1. www.retrovirology.com/supplements/5/S1.
4. Centers for Disease Control and Prevention (CDC). Achievements in public health: reduction in perinatal transmission of HIV infection-United States, 1985-2005. MMWR Morb Mortal Wkly Rep 2006; 55:592-597.
5. MarazziCM,Germano P, Liotta G,Guidotti G, Loureiro S,Gomes AC, et al. Implementing antiretroviral triple therapy to prevent Mother-to-Child HIV transmission: a public health approach in resource-limited settings. Eur J Ped 2007; 166:1305-1307.
6. Palombi L, Marazzi MC, Voetberg A, Magid NA. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. AIDS 2007; 21: S65-S71.
7. Marazzi MC, Nielsen-Saines K, Buonomo E, Scarcella P, Germano P,MajidNA, et al. Increased infant humanimmunodeficiency virus-type one free survival at one year of age in subSaharan Africa with maternal use of highly active antiretroviral therapy during breastfeeding. Pediatr Infect Dis J 2009; 28:483-487.
8. World Health Organization. World Health Statistics 2008. WHO Library Cataloguing-in-Publication Data. ISBN 978 92 4 0682740.
9. Palombi L, Buonomo E, Scarcella P, Doro Altan AM, Nielsen- Saines K, Tembo D, et al. Provision of highly active antiretroviral therapy (HAART) to mothers while breastfeeding and nutritional supplementation during the weaning process favorably impacts infant growth and survival in African HIV-exposed infants. In: Proceedings of the 5TH IAS Conference on HIV Pathogenesis, Treatment and Prevention; 19-22 July 2009; Cape Town, South Africa. Abstract TUPEC044.
10. Marazzi MC, Palombi L, Nielsen-Saines K, Haswell J, Maulidi M, Luhanga R, et al. Favorable pregnancy outcomes with reduction of abortion, stillbirth, and prematurity rates in a large cohort of HIVR women in southern Africa receiving Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother- Child-Transmission (PMTCT). In: Proceedings of the 5TH IAS Conference on HIV Pathogenesis, Treatment and Prevention;19- 22 July 2009; Cape Town, South Africa. Abstract TUAC102.
11. World Health Organization. Rapid advice: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. http://www.who.int/hiv/pub/mtct/advice/en/. [Accessed 21 April 2010).
12. Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 2008; 359:119-129.
13. Espo M, Kulmala T, Maleta K, Cullinan T, Salin ML, Ashorn P. Determinants of linear growth and predictors of severe stunting during infancy in rural Malawi. Acta Paediatr 2002; 91:1364-1370.
14. Kuhn L, Sinkala M, Semrau K, Kankasa C, Kasonde P, Mwiya M, et al. Elevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIV-infected mothers. Clin Infect Dis 2010; 50:437-444.
15. Marinda E, Humphrey JH, Iliff PJ, Mutasa K, Nathoo KJ, Piwoz EG, et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 2007; 26:519-526.
16. Peltier CA, Ndayisaba GF, Lepage P, van Griensven J, Leroy V, Pharm CO, et al. Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal motherto- child transmission in Rwanda. AIDS 2009; 23:2415-2423.
17. Thior I, Lockman S,SmeatonLM, Shapiro RL,Wester C,Heymann SJ, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 2006; 296:794-805.